Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 2 | 1 | — | — | 3 |
Lung neoplasms | D008175 | — | C34.90 | 2 | 1 | 1 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 5 | 1 | — | — | — | 6 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 2 | — | — | — | 3 |
Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | — | 2 | — | — | — | 2 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | — | 1 | — | — | — | 1 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 1 | — | — | — | 1 |
Thyroid diseases | D013959 | — | E00-E07 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | 1 | — | — | — | — | 1 |
Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | — | 1 |
Colonic neoplasms | D003110 | — | C18 | 1 | — | — | — | — | 1 |
Rectal neoplasms | D012004 | — | — | 1 | — | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | 1 | — | — | — | — | 1 |
Drug common name | Motesanib |
INN | motesanib |
Description | Motesanib is a pyridinecarboxamide. |
Classification | Small molecule |
Drug class | angiogenesis inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21 |
PDB | — |
CAS-ID | 453562-69-1 |
RxCUI | — |
ChEMBL ID | CHEMBL572881 |
ChEBI ID | 51098 |
PubChem CID | 11667893 |
DrugBank | — |
UNII ID | U1JK633AYI (ChemIDplus, GSRS) |